GB1365469A - Steroids of the d-homopregnane series - Google Patents

Steroids of the d-homopregnane series

Info

Publication number
GB1365469A
GB1365469A GB1511273A GB1511273A GB1365469A GB 1365469 A GB1365469 A GB 1365469A GB 1511273 A GB1511273 A GB 1511273A GB 1511273 A GB1511273 A GB 1511273A GB 1365469 A GB1365469 A GB 1365469A
Authority
GB
United Kingdom
Prior art keywords
acetoxy
dihydroxy
hydroxy
prepared
ene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1511273A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1365469A publication Critical patent/GB1365469A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B19/00Oxazine dyes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1365469 D-homosteroids F HOFFMANNLA ROCHE & CO AG 29 March 1973 [29 March 1972] 15112/73 Headings C2U and C2C The invention comprises compounds of formula (wherein R<SP>6</SP> is H, F, Cl or Me; R<SP>9</SP> is H, F, Cl or Br; and R<SP>17</SP> and R<SP>21</SP> are each hydroxy or acyloxy), and the 1,2-dehydro derivatives thereof; and their preparation by (i) microbial 11#- hydroxylation of the corresponding 11-unsubstituted compounds; (ii) reaction of the corresponding 21-halo compounds with alkali metal acylates to give 21-acyloxy compounds; (iii) addition of HOCl or HOBr across the double bond of the corresponding #<SP>9(11)</SP>-compounds; (iv) hydrohalogenation of the corresponding 9#,11#-epoxides; (v) 4,5-dehydration of the corresponding 5α-ols; (vi) reduction of the corresponding 11-ones (with protection of the 3- and 20-oxo groups); (vii) oxidation of the corresponding 17a(20)-enes to introduce the 17aα-hydroxy-20-oxo-grouping; and (viii) 4,5- dehydrohalogenation of the corresponding 5#,6#-dichloro compounds. Interconversions of compounds I are: (i) 1,2-dehydrogenation (chemical or microbial); (ii) saponification of 17- or 21-acyloxy groups; (iii) 6# # 6α isomerization; (iv) 6-halogenation; and (v) acylation of 17- and 21-hydroxy groups. D-Homocortisone 21-acetate is formed as a by-product in the preparation of 9α-fluoro-D- homocortisol 21-acetate by preparation (iv). 11#,17aα - Dihydroxy - D - homopregn - 4- ene - 3,20 - dione (XXI) is prepared from 3,11#- diacetoxyandrosta-3,5-dien-17-one (XX) by the sequence: XX # 3,11# - diacetoxy - 17,17 - ethylenedioxyandrosta - 3,5 - diene # 3# - hydroxy- 11# - acetoxy - 17, 17 - ethylenedioxyandrost-5- ene # 3# - hydroxy - 11# - acetoxyandrost - 5- en - 17 - one # 3# - hydroxy - 11# - acetoxy- 17,20 - epoxy - 21 - norpregn - 5 - ene # 3#,17#- dihydroxy - 11# - acetoxy - 17#- aminomethylandrost - 4 - ene # 3# - hydroxy - 11# - acetoxy- D - homoandrost - 5 - en - 17a - one # 3#,11#- dihydroxy - D - homoandrost - 5 en - 17a - one # 3#,11# - dihydroxy - D - homopregna - 5,17a(20)- diene # 11# - hydroxy - D - homopregna - 4,17a- (20)-dien-3-one # XXI. 11#,17aα - Dihydroxy - 21 - iodo - D - homopregn - 4 - ene - 3,20 - dione is prepared from XXI with I 2 /CaO/CaCl 2 /MeOH. 11#,17aα - Dihydroxy - D - homopregna- 1,4 - diene - 3,20 - dione is prepared from XXI with Arthrobacter Simplex. 6α- and 6# - Fluoro - 11#,17aα - dihydroxy- D - homo - pregn - 4 - ene - 3,20 - dione are prepared from XXI via 3-ethoxy-11#,17aα-dihydroxy - D - homopregna - 3,5 - dien - 20 - one. The 6#-isomer can be isomerized to the 6α- isomer using HBr/AcOH. 17aα - Hydroxy - 21 - acetoxy - D - homopregna - 4,9(11) - diene - 3,20- dione and the corresponding 1,4,9(11)-triene are prepared by dehydration of the corresponding 11#-ols. 9#,11# - Epoxy - 17aα - hydroxy - 21 - acetoxy- D - homopregn - 4 - ene - 3,20 - dione and the #<SP>1,4</SP> and 6α-fluoro-#<SP>1,4</SP> analogues thereof are prepared from the corresponding 9α-bromo- 11#-ols by refluxing with KOAc/EtOH. 3 - Ethoxy - 11#, 17aα- dihydroxy - 21 - acetoxy- D - homopregna - 3,5 - dien - 20 - one is prepared from the corresponding 4-en-3-one with triethyl orthoformate. 5α,6α - Dichloro - 11#,17aα - dihydroxy - 21- acetoxy - D - homopregnane - 3,20 - dione is prepared from 11#,17aα-dihydroxy-21-acetoxy- D-homopregn-4-ene-3,20-dione via 3,3-ethylenedioxy - 11#,17aα - dihydroxy - 21 - acetoxy - D- homopregn-5-en-20-one (XXII). 5α,11#,17aα - Trihydroxy - 6# - chloro - 21 acetoxy - D - homopregnane - 3,20 - dione is prepared from XXII via 3,3, - ethylenedioxy- 5,6 - epoxy - 11#, 17aα - dihydroxy - 21 - acetoxy- D - homopregnan - 20 - one and 3,3 - ethylenedioxy - 5α,11#,17aα - trihydroxy - 6# - chloro- 21-acetoxy-D-homopregnan-20-one. A 3,20-disemicarbazone is prepared from 17aα- hydroxy - 21 - acetoxy - D - homopregn - 4- ene-3,11,20-trione. Anti-inflammatory compositions for oral, parenteral, rectal and topical administration comprise a compound of Formula I and a carrier.
GB1511273A 1972-03-29 1973-03-29 Steroids of the d-homopregnane series Expired GB1365469A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466672A CH571018A5 (en) 1972-03-29 1972-03-29

Publications (1)

Publication Number Publication Date
GB1365469A true GB1365469A (en) 1974-09-04

Family

ID=4280344

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1511273A Expired GB1365469A (en) 1972-03-29 1973-03-29 Steroids of the d-homopregnane series

Country Status (27)

Country Link
JP (2) JPS5844360B2 (en)
KR (3) KR780000672B1 (en)
AR (1) AR208389A1 (en)
AT (1) AT326282B (en)
AU (1) AU468918B2 (en)
BE (1) BE797412A (en)
CA (1) CA1006156A (en)
CH (1) CH571018A5 (en)
DD (1) DD105216A5 (en)
DE (1) DE2314592C2 (en)
DK (1) DK135722B (en)
ES (13) ES413083A1 (en)
FI (1) FI52099C (en)
FR (1) FR2182911B1 (en)
GB (1) GB1365469A (en)
HU (2) HU166580B (en)
IE (1) IE37444B1 (en)
IL (1) IL41752A (en)
LU (1) LU67304A1 (en)
NL (1) NL176945C (en)
NO (1) NO139524C (en)
PH (1) PH9660A (en)
PL (7) PL98710B1 (en)
SE (2) SE404530B (en)
SU (7) SU492080A3 (en)
YU (4) YU35775B (en)
ZA (1) ZA731563B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202841A (en) * 1977-08-25 1980-05-13 Hoffmann-La Roche Inc. D-Homopregnanes

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK142289B (en) * 1973-03-28 1980-10-06 Hoffmann La Roche Analogous procedure for the preparation of D-homopregn-4-ene-3,20-dione.
DE2442615A1 (en) * 1974-09-04 1976-03-18 Schering Ag NEW D-HOMO-STEROIDS
SE411351B (en) * 1974-10-07 1979-12-17 Hoffmann La Roche PROCEDURE FOR THE PREPARATION OF D-HOMOSTEROIDS FROM THE PREGNANCY SERIES
SE427276B (en) * 1975-04-03 1983-03-21 Hoffmann La Roche PROCEDURE FOR PREPARING D-HOMOSTEROIDS
AT356301B (en) * 1976-09-03 1980-04-25 Hoffmann La Roche METHOD FOR THE PRODUCTION OF NEW D-HOMOSTEROIDS
DE3038855A1 (en) * 1980-10-10 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen NEW D-HOMO CORTICOIDS, THEIR PRODUCTION AND USE
DE3409554A1 (en) * 1984-03-13 1985-09-19 Schering AG, 1000 Berlin und 4709 Bergkamen NEW 6 (ALPHA) METHYL-D HOMO CORTICOIDS
JPH0356125Y2 (en) * 1985-07-30 1991-12-16

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202841A (en) * 1977-08-25 1980-05-13 Hoffmann-La Roche Inc. D-Homopregnanes

Also Published As

Publication number Publication date
ES439951A1 (en) 1977-07-01
SU697054A3 (en) 1979-11-05
AT326282B (en) 1975-12-10
PL92076B1 (en) 1977-03-31
YU81573A (en) 1980-12-31
JPS5877899A (en) 1983-05-11
IL41752A0 (en) 1973-05-31
IE37444L (en) 1973-09-29
ES439952A1 (en) 1977-07-01
ES439948A1 (en) 1977-07-01
HU170428B (en) 1977-06-28
SU612636A3 (en) 1978-06-25
NL7304193A (en) 1973-10-02
ES439950A1 (en) 1977-07-01
YU35775B (en) 1981-06-30
YU35452B (en) 1981-02-28
NO139524B (en) 1978-12-18
HU166580B (en) 1975-04-28
SU538665A3 (en) 1976-12-05
KR780000673B1 (en) 1978-12-26
SU506288A3 (en) 1976-03-05
PH9660A (en) 1976-01-27
NO139524C (en) 1979-03-28
ES439956A1 (en) 1977-06-01
DE2314592C2 (en) 1983-04-14
DK135722B (en) 1977-06-13
SU517263A3 (en) 1976-06-05
IE37444B1 (en) 1977-07-20
ES439957A1 (en) 1977-06-01
PL98712B1 (en) 1978-05-31
AU468918B2 (en) 1976-01-29
ZA731563B (en) 1973-11-28
PL92130B1 (en) 1977-03-31
DK135722C (en) 1977-11-14
YU35453B (en) 1981-02-28
ES439953A1 (en) 1977-06-16
SE7602850L (en) 1976-02-27
PL98710B1 (en) 1978-05-31
NL176945C (en) 1985-07-01
SU509211A3 (en) 1976-03-30
KR780000672B1 (en) 1978-12-26
AU5320773A (en) 1974-09-12
ES439959A1 (en) 1977-06-01
JPS6052160B2 (en) 1985-11-18
IL41752A (en) 1977-11-30
LU67304A1 (en) 1974-10-09
SU492080A3 (en) 1975-11-15
JPS495960A (en) 1974-01-19
CA1006156A (en) 1977-03-01
SE404530B (en) 1978-10-09
DD105216A5 (en) 1974-04-12
FR2182911A1 (en) 1973-12-14
DE2314592A1 (en) 1973-10-11
NL176945B (en) 1985-02-01
ES439958A1 (en) 1977-06-01
PL98714B1 (en) 1978-05-31
ES439954A1 (en) 1977-06-01
YU56879A (en) 1980-09-25
FI52099C (en) 1977-06-10
PL86797B1 (en) 1976-06-30
ES439955A1 (en) 1977-06-01
FR2182911B1 (en) 1976-10-22
CH571018A5 (en) 1975-12-31
KR780000675B1 (en) 1978-12-26
ES439949A1 (en) 1977-07-01
YU56979A (en) 1980-09-25
ATA270973A (en) 1975-02-15
AR208389A1 (en) 1976-12-27
FI52099B (en) 1977-02-28
PL92077B1 (en) 1977-03-31
BE797412A (en) 1973-09-28
ES413083A1 (en) 1976-06-01
JPS5844360B2 (en) 1983-10-03

Similar Documents

Publication Publication Date Title
GB1159490A (en) Improvements in Acylated Steroids
GB1494097A (en) D-homo-20-keto-pregnanes
GB1445945A (en) Steroids of the d-homo-pregnane series
GB1365469A (en) Steroids of the d-homopregnane series
GB1190403A (en) 4-Hydroxy-2-Butenoic Acid Lactones
US3681410A (en) Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof
US3164618A (en) Alkylated steroids
GB1327950A (en) 21-mercapto-steroids of the pregnane series and a process for their manufacture
US3375260A (en) 19-nor-9beta, 10alpha-steroids of the pregnane series
GB1211836A (en) Novel 15,16-alkylidene-steroids and a process for the manufacture thereof
US3376291A (en) 17alpha-dihalopregneno[3, 2-c]pyrazoles and process for their preparation
GB928302A (en) í¸-pregnene compounds
US3519619A (en) 16-alkylidene pregnanes and process for their manufacture
GB1530615A (en) 15,16-methylene-steroids of the pregnane series
GB1273024A (en) 07alpha-ALKADIENYL STEROIDS
US3228933A (en) 3-enol ethers of 6-methyl-3-oxo-deta4-steroids and process for preparing same
GB1228211A (en)
GB1269160A (en) New pregnane derivatives
US3126398A (en) Fluorevated androstenes and process
US3438977A (en) 6,7-methylene and 6,7-halomethylene pregnanes and 19-norpregnanes and process for their preparation
Gilbert et al. The progestational and anti-estrogenic activities of some novel 11β-substituted steroids
US3053858A (en) 10-fluoro-19-nor steroids
US3591582A (en) Process for preparing alpha-acyloxy ketone steroids
US3453295A (en) Process for preparing 3-keto-19-nor-delta**4,9(10) steroids
US3126376A (en) Fluorinated anbrostenes and inter-

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee